EXOSC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.250600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.261800E-01
Normal-vs-Stage2
5.545000E-01
Normal-vs-Stage3
3.064600E-01
Normal-vs-Stage4
8.617200E-01
Stage1-vs-Stage2
6.353800E-01
Stage1-vs-Stage3
2.471200E-01
Stage1-vs-Stage4
3.284600E-01
Stage2-vs-Stage3
1.429760E-01
Stage2-vs-Stage4
7.123400E-01
Stage3-vs-Stage4
1.651990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.471000E-01
Normal-vs-AfricanAmerican
6.168200E-01
Normal-vs-Asian
9.230800E-01
Caucasian-vs-AfricanAmerican
6.218800E-01
Caucasian-vs-Asian
1.105010E-01
AfricanAmerican-vs-Asian
7.105800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.546200E-01
Normal-vs-Female
6.319800E-01
Male-vs-Female
4.012800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.177200E-01
Normal-vs-Age(41-60Yrs)
8.444800E-01
Normal-vs-Age(61-80Yrs)
3.745000E-01
Normal-vs-Age(81-100Yrs)
7.484800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.294600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.494800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.457400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.686300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.812800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.409200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.850200E-01
Normal-vs-Daily Drinker
6.000200E-01
Normal-vs-Weekly Drinker
8.841600E-01
Normal-vs-Occasional Drinker
6.531600E-01
Normal-vs-Social Drinker
9.188800E-01
Non Drinker-vs-Daily Drinker
5.327000E-01
Non Drinker-vs-Weekly Drinker
2.971000E-01
Non Drinker-vs-Occasional Drinker
5.171600E-01
Non Drinker-vs-Social Drinker
2.817800E-01
Daily Drinker-vs-Weekly Drinker
5.477000E-01
Daily Drinker-vs-Occasional Drinker
9.328400E-01
Daily Drinker-vs-Social Drinker
5.272600E-01
Weekly Drinker-vs-Occasional Drinker
6.255200E-01
Weekly Drinker-vs-Social Drinker
9.564000E-01
Occasional Drinker-vs-Social Drinker
6.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.733200E-01
Normal-vs-Grade 2
9.524600E-01
Normal-vs-Grade 3
9.902400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.152000E-02
Grade 1-vs-Grade 3
4.520200E-02
Grade 1-vs-Grade 4
8.733200E-01
Grade 2-vs-Grade 3
3.383800E-01
Grade 2-vs-Grade 4
9.524600E-01
Grade 3-vs-Grade 4
9.902400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.625200E-01
Normal-vs-NonDiabetic
6.161000E-01
Diabetic-vs-NonDiabetic
2.887600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.294800E-01
Normal-vs-NoPancreatitis
5.489000E-01
Pancreatitis-vs-NoPancreatitis
6.085400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.471800E-01
Normal-vs-N1
5.031800E-01
N0-vs-N1
4.952800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.806800E-01
Normal-vs-TP53-NonMutant
7.950000E-01
TP53-Mutant-vs-TP53-NonMutant
6.152100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
